Funding for this research was provided by:
Show Chwan Memorial Hospital, Changhua, Taiwan (RD105014, RD106047)
Received: 19 October 2021
Accepted: 2 November 2022
First Online: 18 November 2022
: This randomized, double-blind, parallel-designed, active-control trial was ethically approved by the Institutional Review Board in Show Chwan Memorial Hospital (No. RA16010) and retrospectively registered on 20 August 2021 (ClinicalTrials.gov: NCT05023122). All participants provided written informed consents.
: Not applicable.
: All authors declare no conflict of interests.